Welcome to Medications.com

Prevacid Information

What's inside Prevacid

Prevacid Active Ingredients: lansoprazole, details.
Prevacid Dosages & Strengths
Strength Format Route Strength Class
Prevacid 15 mg delayed release capsule oral 1.0 each OTC
Prevacid 30 mg delayed release capsule oral 1.0 each OTC
Prevacid 30 mg granule for reconstitution oral 1.0 each OTC
Prevacid 15 mg granule for reconstitution oral 1.0 each OTC

Recent Prevacid Side Effects

Posted by jeannineloretta 6 months ago
I had extreme hair loss in February 2008 while taking Prevacid. I got off of it and began taking Protonix and my hair began ...

Posted by donewithprevacid about 1 year ago
I was on prevacid for about 2+ years. I tried to get off of it several times without success. I tried a 21 day weight loss ...

Posted by cbrock1303 about 1 year ago
In February of 2008 I took 8 capsules over a period of 14 days, The second day I had a hedache and tightness in the chest-abd...


Prevacid in the News

Santarus Q4 2007 Earnings Call Transcript - Seeking Alpha
In early January, we reported positive results from a clinical trial with immediate-release Zegerid capsule and Protonix delayed-release tablet and Prevacid ...
Mon Mar 03 22:29:50 -0500 2008

FDA Approves Drug For Children With Reflux - KDKA
Until now, only one medication called Prevacid has been approved for children diagnosed with reflux, where the stomach acid flows back and erodes the ...
Fri Feb 29 17:23:25 -0500 2008

Elway: Still Loving The Drive (Thru) - TMZ.com
In 2003, John revealed he suffers from acid reflux disease and served as a spokesman for PREVACID, a treatment medication.
Tue Feb 26 11:32:25 -0500 2008


Prevacid Chemical Information

lansoprazole - A substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity. Lansoprazole prodrug is converted to an active sulfonamide derivative in the acidic environment of the gastric parietal cell; the sulfonamide derivative binds to the gastric proton pump H+/K+ ATPase and forms a stable disulfide bond with the sulfhydryl group near the potassium-binding site on the luminal side, resulting in inactivation of the ATPase and a reduction in gastric acid secretion. This agent does not have anticholinergic or histamine H2 -receptor antagonistic properties.



Related Drugs
Related drugs contain similar ingredients


© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea